GPCRs Drug Discovery

G protein-coupled receptors (GPCRs) belong to a great domestic of cell surface signaling proteins that have a pivotal role in many biological functions and in multiple diseases, including the development of cancer and cancer metastasis. Naturally, a number of drugs based on GPCRs have been industrialized for such different indications as cardiovascular, metabolic, neurodegenerative, psychiatric, and oncologic diseases. Owing to the restricted structural information on GPCRs, only limited exploration of structure-based drug design has been possible. Current drugs that target GPCRs - many of which have tremendous therapeutic benefits - are directed towards only a few GPCR members. Therefore, huge determinations are currently proceeding to develop new GPCR-based drugs. We review recent findings that present unexpected opportunities to interfere with main tumorigenic signals by manipulating GPCR-mediated pathways. We also discuss current data concerning novel GPCR targets that may provide talented opportunities for drug discovery in cancer prevention and treatment.

G protein-coupled receptors (GPCRs) belong to a great domestic of cell surface signaling proteins that have a pivotal role in many biological functions and in multiple diseases, including the development of cancer and cancer metastasis. Naturally, a number of drugs based on GPCRs have been industrialized for such different indications as cardiovascular, metabolic, neurodegenerative, psychiatric, and oncologic diseases. Owing to the restricted structural information on GPCRs, only limited exploration of structure-based drug design has been possible. Current drugs that target GPCRs - many of which have tremendous therapeutic benefits - are directed towards only a few GPCR members. Therefore, huge determinations are currently proceeding to develop new GPCR-based drugs. We review recent findings that present unexpected opportunities to interfere with main tumorigenic signals by manipulating GPCR-mediated pathways. We also discuss current data concerning novel GPCR targets that may provide talented opportunities for drug discovery in cancer prevention and treatment.

  • GPCR Signaling
  • Targeting Drug on GPCR
  • Novel Targeting on GPCR
  • GPCR Crystallography in Drug Discovery
  • GPCR Structures in Drug Discovery
  • Tools for GPCR Drug Disocvery
  • Biosensors GPCR Probing Conformation
  • GPCR Screening Method for Drug Discovery

Related Conference of GPCRs Drug Discovery

July 03-04, 2017

4th Annual Congress on Drug Discovery & Designing

Bangkok, Thailand
August 10-12, 2017

8th Asian Biologics and Biosimilars Congress

Beijing, China
September 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 02-04, 2017

World Congress on Antibiotics: R&D, Market

Atlanta, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria

GPCRs Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in